Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
4
×
life sciences
national blog main
biotech
clinical trials
san francisco blog main
akouos
boston
cancer
deals
fda
san francisco top stories
abbvie
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
astellas pharmaceuticals
astrazeneca
avapritinib
biogen
blueprint medicines
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
california institute for biomedical research
cancer diagnostics
cancer immunotherapy
cerovene
covid-19
crispr
decibel therapeutics
deciphera pharmaceuticals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
What
plans
4
×
announced
cancer
developing
drug
fda
ipo
medicine
medicines
acquisitions
affects
americans
approval
approved
area
based
bay
bio
biopsy
blood
blueprint
buildout
ceo
chasing
close
collabs
company
covid
daniel
date
deadly
deal
deciphera
filing
firm
forms
frequency
genomic
gi
gilead
Language
unset
4
×
Current search:
plans
×
" boston blog main "
×
unset
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug